X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Book Chapter (888) 888
Journal Article (472) 472
Conference Proceeding (14) 14
Newspaper Article (11) 11
Patent (4) 4
Publication (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (342) 342
life sciences & biomedicine (285) 285
humans (225) 225
female (131) 131
male (124) 124
middle aged (79) 79
risk factors (69) 69
aged (67) 67
general & internal medicine (64) 64
research (61) 61
medicine, general & internal (60) 60
animals (56) 56
cardiovascular disease (56) 56
adult (55) 55
cardiovascular system & cardiology (54) 54
abridged index medicus (53) 53
analysis (53) 53
cardiac & cardiovascular systems (50) 50
studies (47) 47
cardiovascular diseases (41) 41
research article (40) 40
gene expression (38) 38
mice (38) 38
mortality (38) 38
health aspects (37) 37
medical research (36) 36
science & technology - other topics (36) 36
multidisciplinary sciences (35) 35
care and treatment (34) 34
diabetes (32) 32
oncology (32) 32
coronary heart disease (31) 31
medicine (31) 31
patients (30) 30
cancer (29) 29
hypertension (28) 28
science (25) 25
physical sciences (24) 24
prevention (24) 24
genetic aspects (23) 23
public, environmental & occupational health (23) 23
text messaging (23) 23
usage (23) 23
blood pressure (22) 22
cardiovascular (21) 21
proteins (21) 21
cardiology (20) 20
clinical trials (20) 20
disease prevention (20) 20
epidemiology (20) 20
genetics (20) 20
public health (20) 20
surveys and questionnaires (20) 20
exercise (19) 19
health risk assessment (19) 19
heart attacks (19) 19
prospective studies (19) 19
surgery (19) 19
1506 (18) 18
cell biology (18) 18
cell line, tumor (18) 18
diagnosis (18) 18
cardiovascular diseases - epidemiology (17) 17
health care sciences & services (17) 17
risk assessment (17) 17
smoking (17) 17
biology (16) 16
cardiovascular diseases - prevention & control (16) 16
chronic illnesses (16) 16
cross-sectional studies (16) 16
gene expression profiling (16) 16
gravitational waves (16) 16
hospitals (16) 16
intervention (16) 16
mhealth (16) 16
mutation (16) 16
secondary prevention (16) 16
systematic review (16) 16
biochemistry & molecular biology (15) 15
education (15) 15
genetics & heredity (15) 15
india (15) 15
medicine, experimental (15) 15
myocardial infarction (15) 15
physics (15) 15
quality of life (15) 15
socioeconomic factors (15) 15
aged, 80 and over (14) 14
follow-up studies (14) 14
genomes (14) 14
heart diseases (14) 14
india - epidemiology (14) 14
internal medicine (14) 14
life style (14) 14
medication adherence (14) 14
prevalence (14) 14
rural population (14) 14
time factors (14) 14
treatment outcome (14) 14
coronary artery disease (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Index Medicus | Abridged Index Medicus | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
The American heart journal, ISSN 0002-8703, 2009, Volume 158, Issue 1, pp. 1 - 7.e1
Journal Article
The Lancet (British edition), ISSN 0140-6736, 01/2016, Volume 387, Issue 10013, pp. 61 - 69
Summary Background WHO has targeted that medicines to prevent recurrent cardiovascular disease be available in 80% of communities and used by 50% of eligible... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Drug Costs | Platelet Aggregation Inhibitors - economics | Cardiovascular Diseases - drug therapy | Humans | Income | Malaysia | Secondary Prevention | Aspirin - supply & distribution | Urban Population | Angiotensin-Converting Enzyme Inhibitors - supply & distribution | Angiotensin-Converting Enzyme Inhibitors - economics | Sweden | Pakistan | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Iran | Rural Population | China | Adrenergic beta-Antagonists - economics | Brazil | Poland | Aspirin - therapeutic use | Aspirin - economics | Chile | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Agents - economics | Colombia | Argentina | Platelet Aggregation Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics | United Arab Emirates | Adrenergic beta-Antagonists - supply & distribution | India | Pharmacies | Canada | Cardiovascular Agents - supply & distribution | Cardiovascular Agents - therapeutic use | Bangladesh | Family Characteristics | Developed Countries | Turkey | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | South Africa | Zimbabwe | Developing Countries | Drugs | Prevention | Usage | Cardiovascular diseases | Analysis | Disease prevention | Cardiovascular disease | Costs | Health care access | Preventive medicine | Health risk assessment | Index Medicus | Abridged Index Medicus | Klinisk medicin | Clinical Medicine
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2012, Volume 60, Issue 14, pp. 1207 - 1216
Journal Article
The Lancet (British edition), ISSN 0140-6736, 08/2019, Volume 394, Issue 10199, pp. 613 - 615
Journal Article
American Heart Journal, ISSN 0002-8703, 2013, Volume 166, Issue 4, pp. 636 - 646.e4
Journal Article
The Lancet global health, ISSN 2214-109X, 10/2016, Volume 4, Issue 10, pp. e695 - e703
Journal Article